Work

Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia

Year: 2019

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2019.1608533

Authors: Jacob D. Soumerai, Matthew S. Davids, Lillian Werner, David C. Fisher, Philippe Armand, Philip C. Amrein, Donna Neuberg, Ephraim P. Hochberg, Jennifer R. Brown, Jeremy S. Abramson

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Lymphoma Research Foundation, AstraZeneca, Celgene

Award: G6261188124

OpenAlex ID: W2944533212

FWCI: 0.464

Cites: 25

Cited by: 6

Related to: 10